Treatment of Chronic Fatigue Syndrome in the Antiviral Revolution Era: What Does the Research Say?

Are viruses the key to understanding this mysterious, devastating disease? Chronic fatigue syndrome (CFS) causes great suffering, not least because its etiology is so poorly understood. Treatment of Chronic Fatigue Syndrome in the Antiviral Revolution Era offers proof that viruses may be direct or indirect causes of the disease. Therefore the new antiviral agents, the first fruits of the expanding genomics revolution, may be of use in treating this disorder. In recent years, innovative hypotheses on disease have challenged conventional medical wisdom. New studies give powerful evidence that pathological processes as diverse as atherosclerosis and autoimmune disease may be of viral origin. Treatment of Chronic Fatigue Syndrome in the Antiviral Revolution Era takes these ideas a step further and applies them to CFS, offering fresh possibilities for treating this debilitating disease. This breakthrough book presents the latest research on antiviral agents, including: the scientific rationale for their use in CFS the historical evolution of these drugs results of clinical trials new lines of research It also offers updates on specific drugs and treatments, including: Acyclovir, Ampligen, Imunovir (Inosine Pranobex), and 2CVV vaccines against Epstein-Barr virus, influenza, staphylococcus, and stealth virus Interferon-Alpha ginseng and other herb-based antivirals . . . and many more! Treatment of Chronic Fatigue Syndrome in the Antiviral Revolution Era is an essential resource for physicians, researchers, virologists, and patient advocates, as well as for anyone who is trying to obtain the best possible treatment for CFS.